Robert G. Uzzo

36.1k total citations · 10 hit papers
552 papers, 23.9k citations indexed

About

Robert G. Uzzo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Robert G. Uzzo has authored 552 papers receiving a total of 23.9k indexed citations (citations by other indexed papers that have themselves been cited), including 361 papers in Pulmonary and Respiratory Medicine, 191 papers in Molecular Biology and 171 papers in Surgery. Recurrent topics in Robert G. Uzzo's work include Renal cell carcinoma treatment (247 papers), Renal and related cancers (152 papers) and Bladder and Urothelial Cancer Treatments (128 papers). Robert G. Uzzo is often cited by papers focused on Renal cell carcinoma treatment (247 papers), Renal and related cancers (152 papers) and Bladder and Urothelial Cancer Treatments (128 papers). Robert G. Uzzo collaborates with scholars based in United States, Canada and Italy. Robert G. Uzzo's co-authors include Alexander Kutikov, Andrew C. Novick, Richard E. Greenberg, Brian L. Egleston, David Y.T. Chen, David A. Kunkle, Marc C. Smaldone, Vladimir Kolenko, Rosalia Viterbo and Steven C. Campbell and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Robert G. Uzzo

529 papers receiving 23.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth

2009 1.7k citations Alexander Kutikov, Robert G. Uzzo profile →
Guideline for Management of the Clinical T1 Renal Mass

2009 1.4k citations Andrew C. Novick, Paul Russo et al. profile →
Renal Mass and Localized Renal Cancer: AUA Guideline

2017 850 citations Robert G. Uzzo, Peter E. Clark et al. profile →
NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMES

2001 698 citations Robert G. Uzzo, Andrew C. Novick profile →
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work

2013 539 citations Robert G. Uzzo et al. profile →
The Natural History of Observed Enhancing Renal Masses: Meta-Analysis and Review of the World Literature

2006 518 citations Paul L. Crispen, Richard E. Greenberg et al. profile →
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-Up: AUA Guideline: Part I

2021 359 citations Peter E. Clark, Robert G. Uzzo et al. profile →
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies

2018 359 citations Alexander Kutikov, Robert G. Uzzo et al. profile →
Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer

2013 340 citations Eric M. Horwitz, Richard E. Greenberg et al. Journal of Clinical Oncology profile →
A War on Two Fronts: Cancer Care in the Time of COVID-19

2020 288 citations Alexander Kutikov, Eric M. Horwitz et al. profile →

Peers

Countries citing papers authored by Robert G. Uzzo

Since Specialization

Citations

This map shows the geographic impact of Robert G. Uzzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert G. Uzzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert G. Uzzo more than expected).

Fields of papers citing papers by Robert G. Uzzo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert G. Uzzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert G. Uzzo. The network helps show where Robert G. Uzzo may publish in the future.

Co-authorship network of co-authors of Robert G. Uzzo

This figure shows the co-authorship network connecting the top 25 collaborators of Robert G. Uzzo. A scholar is included among the top collaborators of Robert G. Uzzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert G. Uzzo. Robert G. Uzzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma 2025 ·Annals of Oncology ·Brian I. Rini, Laurence Albigès, Xiaobin Tang, Hartmut Koeppen, Axel Bex, (unknown), Robert G. Uzzo, Habib Hamidi, Zoe J. Assaf, (unknown), (unknown), (unknown), Pål Kristian Selbo, Romain Banchereau, Wenxin Xu, Mahrukh Huseni	0
2	Circulating kidney injury molecule-1 (KIM-1) biomarker analysis in IMmotion010: A randomized phase 3 study of adjuvant (adj) atezolizumab (atezo) vs placebo (pbo) in patients (pts) with renal cell carcinoma (RCC) at increased risk of recurrence after resection. 2024 ·Journal of Clinical Oncology ·Laurence Albigès, Axel Bex, Cristina Suárez, Robert G. Uzzo, Xiaobin Tang, Zoe J. Assaf, Sarita Dubey, Erik T. Goluboff, Corey Carter, Romain Banchereau, (unknown), Sumanta K. Pal, Brian I. Rini	27
3	Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets 2024 ·JCO Precision Oncology ·(unknown), Henkel Valentine, (unknown), John P. Sfakianos, Robert G. Uzzo, Shilpa Gupta, Jason R. Brown, Daniel Ranti, Elizabeth R. Plimack, George Haber, Christopher Weight, Alexander Kutikov, Philip H. Abbosh, Laura Bukavina	2
4	Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas 2023 ·Modern Pathology ·Shuanzeng Wei, (unknown), Daniel M. Geynisman, Andrew Elliott, Alexander Kutikov, Robert G. Uzzo, Jianming Pei, Pedro C. Barata, Benedito A. Carneiro, Elisabeth I. Heath, Charles J. Ryan, Alex Farrell, Chadi Nabhan, Rouba Ali‐Fehmi, Abdul Rafeh Naqash, Pedram Argani, Rana R. McKay	7
5	Localised non‐metastatic sarcomatoid renal cell carcinoma: a 31‐year externally verified study 2023 ·British Journal of Urology ·Kyle A. Blum, Andrew W. Silagy, Andrea Knežević, Stanley Weng, Alan Wang, Roy Mano, Julian Marcon, Renzo G. DiNatale, Alejandro Sánchez, Satish K. Tickoo, Sounak Gupta, Robert J. Motzer, Naomi B. Haas, Se Eun Kim, Robert G. Uzzo, Jonathan Coleman, A. Ari Hakimi, Paul Russo	3
6	Plasma KIM-1 Is Associated with Recurrence Risk after Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805) 2021 ·Clinical Cancer Research ·Wenxin Xu, Mäneka Puligandla, Brian Halbert, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Venkata Sabbisetti, Rupal S. Bhatt	26
7	Influence of Mycosphaerella and Teratosphaeria leaf diseases on chemical composition of essential oils of Eucalyptus globulus and effect of these essential oils on ascospores germination 2021 ·Archives of Microbiology ·(unknown), Julio Massaharu Marubayashi, Robert G. Uzzo, Márcia Ortiz Mayo Marques, (unknown), (unknown), Edson Luiz Furtado	2
8	Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma 2020 ·Clinical Cancer Research ·Robert A. Figlin, Nizar M. Tannir, Robert G. Uzzo, Scott S. Tykodi, David Y.T. Chen, Viraj A. Master, Anil Kapoor, Daniel A. Vaena, William T. Lowrance, Gennady Bratslavsky, Mark DeBenedette, (unknown), (unknown), (unknown), (unknown), Irina Y. Tcherepanova, Charles A. Nicolette, Christopher G. Wood	53
9	Active surveillance of enhancing renal tumors 2020 ·SHILAP Revista de lepidopterología ·Paul L. Crispen, Richard E. Greenberg, (unknown), Robert G. Uzzo	1
10	Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research 2020 ·JNCI Journal of the National Cancer Institute ·Toni K. Choueiri, Michael B. Atkins, Ziad Bakouny, Maria I. Carlo, Charles G. Drake, Eric Jonasch, Payal Kapur, Bryan Lewis, W. Marston Linehan, Michael J. Mitchell, Sumanta K. Pal, (unknown), (unknown), W. Kimryn Rathmell, Brian I. Rini, Sabina Signoretti, Nizar M. Tannir, Robert G. Uzzo, Christopher G. Wood, Hans J. Hammers	15
11	Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma 2019 ·Clinical Cancer Research ·Wenxin Xu, Mäneka Puligandla, Judith Manola, Andrea J. Bullock, Daniel Tamasauskas, David F. McDermott, Michael B. Atkins, Naomi B. Haas, Keith T. Flaherty, Robert G. Uzzo, Janice P. Dutcher, Robert S. DiPaola, Rupal S. Bhatt	11
12	PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth 2019 ·Nature Communications ·Weijia Cai, Liya Su, Lili Liao, Zongzhi Liu, (unknown), Essel Dulaimi, Joseph R. Testa, Robert G. Uzzo, Zhijiu Zhong, Wei Jiang, Qin Yan, Qing Zhang, Haifeng Yang	55
13	Bladder Preservation Therapy: A Review of the Literature and Future Directions 2016 ·Urology ·David Cahn, Benjamin T. Ristau, Eric Ghiraldi, Thomas M. Churilla, Daniel M. Geynisman, Eric M. Horwitz, Robert G. Uzzo, Marc C. Smaldone	12
14	Patient reported outcomes among treatment modalities for prostate cancer. 2016 ·PubMed ·(unknown), Nicholas G. Zaorsky, Jeff M. Martin, Karen Ruth, Richard E. Greenberg, Robert G. Uzzo, S.B. Hayes, Marc C. Smaldone, Alexander Kutikov, Rosalia Viterbo, David Y.T. Chen, M.A. Hallman, Mark L. Sobczak, Eric M. Horwitz	16
15	Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805 2015 ·Clinical Cancer Research ·Naomi B. Haas, Judith Manola, Bonnie Ky, Keith T. Flaherty, Robert G. Uzzo, Christopher J. Kane, Michael A.S. Jewett, Lori Wood, Christopher G. Wood, Michael B. Atkins, Janice Dutcher, George Wilding, Robert S. DiPaola	46
16	The Need for Androgen Deprivation Therapy in Patients With Intermediate-Risk Prostate Cancer Treated With Dose-Escalated External Beam Radiation Therapy 2015 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), K. Ruth, T.M. Churilla, Rosalia Viterbo, (unknown), Marc C. Smaldone, (unknown), Robert G. Uzzo, M.A. Hallman, Eric M. Horwitz	3
17	PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection 2013 ·Cancer Immunology Research ·Alexander W. Macfarlane, (unknown), Elizabeth R. Plimack, Gary R. Hudes, Robert G. Uzzo, Samuel Litwin, Essel Dulaimi, Tahseen Al‐Saleem, Kerry S. Campbell	141
18	Assessing the Clinical Role of Genetic Markers of Early-Onset Prostate Cancer among High-Risk Men Enrolled in Prostate Cancer Early Detection 2012 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), Eric A. Ross, (unknown), Robert G. Uzzo, David Y.T. Chen, Rosalia Viterbo, Timothy R. Rebbeck, Veda N. Giri	11
19	Identification of Novel Target Genes by an Epigenetic Reactivation Screen of Renal Cancer 2006 ·Cancer Research ·Inmaculada Ibañez de Cáceres, Essel Dulaimi, (unknown), Tahseen Al‐Saleem, Robert G. Uzzo, Paul Cairns	133
20	Renal cell carcinoma–derived gangliosides suppress nuclear factor-κB activation in T cells 1999 ·Journal of Clinical Investigation ·Robert G. Uzzo, Patricia Rayman, Vladimir Kolenko, Peter E. Clark, Martha K. Cathcart, Tracy Bloom, Andrew C. Novick, Ronald M. Bukowski, Thomas A. Hamilton, James H. Finke	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact